lobbying_activities: 1807392
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1807392 | 7c8566cb-ac6e-4fe6-a8d8-eca91a26449a | Q1 | BROWN RUDNICK LLP | 287895 | EXELA HOLDINGS, LLC | 2016 | first_quarter | PHA | Federal policy relating to pharmaceutical pricing and FDA application review protocols | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2016-04-14T12:06:34.257000-04:00 |